100869-07-6 Usage
Uses
Used in Sports Nutrition and Dietary Supplements:
2-AMINOMETHYL-4-METHYL-PENTANOIC ACID is used as a nutritional supplement for promoting muscle growth and tissue repair. As an essential amino acid, it supports the body's protein synthesis and helps athletes and individuals engaged in regular physical activity to recover more effectively from exercise-induced muscle damage.
Used in Immune Function Enhancement:
2-AMINOMETHYL-4-METHYL-PENTANOIC ACID is used as an immune-boosting agent to support the body's immune system. Its role in immune function may offer potential benefits for individuals with compromised immune systems or those seeking to improve their overall health and well-being.
Used in Liver and Gallbladder Health:
2-AMINOMETHYL-4-METHYL-PENTANOIC ACID is used as a supportive agent for liver and gallbladder health. Its potential benefits for individuals with liver and gallbladder disorders make it a valuable component in dietary supplements and health products aimed at maintaining liver and gallbladder function.
Used in Pharmaceutical and Biomedical Research:
2-AMINOMETHYL-4-METHYL-PENTANOIC ACID, as a non-proteinogenic amino acid, is used in pharmaceutical and biomedical research for the development of new drugs and therapies. Its unique properties and functions may contribute to the discovery of novel treatments for various health conditions and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 100869-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,8,6 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 100869-07:
(8*1)+(7*0)+(6*0)+(5*8)+(4*6)+(3*9)+(2*0)+(1*7)=106
106 % 10 = 6
So 100869-07-6 is a valid CAS Registry Number.
100869-07-6Relevant articles and documents
Evaluation of several routes to advanced pregabalin intermediates: Synthesis and enantioselective enzymatic reduction using ene-reductases
Debarge, Sebastien,McDaid, Paul,O'Neill, Pat,Frahill, James,Wong, John W.,Carr, Donncha,Burrell, Adam,Davies, Simon,Karmilowicz, Mike,Steflik, Jeremy
, p. 109 - 121 (2014)
This publication describes the evaluation of four synthetic routes to the advanced pregabalin (Lyrica) intermediate 7. Asymmetric reduction of (E)-7 with an ene-reductase (OPR1 from Lycopersicon esculentum) gave a saturated cyanoester intermediate 5 with the desired S stereocenter in ≥99% ee. OPR1 also catalyzed the reduction of (Z)-7 to (S)-5, but with lower conversion and selectivity.